// App-Quantinova.ai

: Impact of infiltrating T cell subtypes on survival and response to FLOT chemotherapy in resectable oesophagogastric adenocarcinoma (OGA).

Researchers

Presenter

  • Avani Athauda

Principal Investigators

  • Tatiany Silveira

  • Thomas Lund

  • Katharina von Loga

  • Benjamin Challoner

  • Isma Rana

  • Janet Thomas

  • Naureen Starling

  • Ian Chau

  • Sheela Rao

  • David J. Watkins

  • David Cunningham

  • Marco Gerlinger

Medical Centers

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cluster of Differentiation 4

  • Forkhead Box P3

  • Programmed cell death protein 1

  • Programmed death-ligand 1

  • Cluster of differentiation 8A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved